Annual Drug Patent Expirations for ADVIL+PM
Advil Pm is a drug marketed by Glaxosmithkline and is included in two NDAs. It is available from four suppliers. There are three patents protecting this drug and two Paragraph IV challenges.
This drug has eleven patent family members in ten countries.
The generic ingredient in ADVIL PM is diphenhydramine citrate; ibuprofen. Four suppliers are listed for this compound. Additional details are available on the diphenhydramine citrate; ibuprofen profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com